Headquarters
597 SCIENCE DR, MADISON, WI 53711-1084, US
MADISON, WI, US
FLUGEN INC
From the company
FluGen, Inc. is developing a more effective vaccine in the fight against influenza and respiratory disease. Its M2SR Vaccine Platform is a clinically-tested vaccine candidate addressing unmet needs in flu prevention, including consistent efficacy, annual virus drift, and shedding. The flagship candidate M2SR is an intranasal, supra-seasonal flu vaccine that stimulates mucosal, humoral, and cellular immunity. Long-term R&D plans include potential application against SARS-CoV-2 (COVID-19) and other respiratory diseases such as RSV.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.